Physician profile
Robert D Brown
NPI 1609830165
$16,494.56
in general payments reported to CMS, 2019-2025
56 companies · $2,666 in 2025
The $2,666 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,017 · 2020: $1,233 · 2021: $2,536 · 2022: $2,538 · 2023: $2,683 · 2024: $2,821 · 2025: $2,666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,169.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $1,974.40 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $1,310.09 | 2019-2025 | |
| Astellas Pharma US INC | $1,162.44 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $1,161.69 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $1,031.38 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $944.20 | 2019-2025 | Botox, Lupron Depot |
| Endo Pharmaceuticals INC. | $940.44 | 2019-2024 | Xiaflex, Aveed, Edex |
| Urogen Pharma, INC. | $669.07 | 2020-2025 | Jelmyto |
| Blue Earth Diagnostics | $617.25 | 2019-2025 | Posluma |
| Pfizer INC. | $546.17 | 2019-2025 | |
| Covidien LP | $540.00 | 2019 | |
| Progenics Pharmaceuticals, INC. | $527.86 | 2021-2025 | Pylarify |
| Antares Pharma, INC. | $524.45 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Novartis Pharmaceuticals Corporation | $488.23 | 2022-2025 | |
| Endo USA, INC. | $450.41 | 2024-2025 | Xiaflex, Aveed |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.